We presented several findings from a range of studies which may indicate that proinflammatory markers (e.g., TNF-α and IL-6) may be responsible for the activation of pathways associated with muscle atrophy in poststroke patients (e.g., UPS system). This evidence concerns the gene TNF and muscle atrophy.